Profile: Synovis Surgical Innovations deals with the development, manufacturing and marketing of implantable biomaterials & surgical tools. Our Peri-Strips Dry® with Veritas® collagen matrix staple line reinforcement remodels into tissue and is indistinguishable from the host tissue. It is derived from bovine pericardium. Its features include multi-directional collagen fibers, open scaffold structure, terminal sterilization and packaged ready to use with hydrogel that creates a temporary bond to the stapler jaws. Its remodelability works in conjunction with the body's natural healing process of biodegradation and biosynthesis. Our Flo-Thru Intraluminal Shunt® offers an atraumatic method of controlling bleeding, temporarily stenting vessels and ensuring myocardial protection during coronary bypass grafting.

The company was founded in 1985, has revenues of USD 50-100 Million and is ISO 9001, CE certified. NASDAQ:SYNO (SEC Filings)

FDA Registration Number: 2183620